<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Evaluation tools":1,
"Internet":1,
"Patient information":1,
"Quality":1,
"Thyroid cancer":82,
"Multiple primary neoplasms":1,
"Neoplasms":5,
"Pancreas":1,
"Prognosis":16,
"Second primary neoplasms":1,
"CXCL12":1,
"CXCR4":1,
"NF-κB":1,
"SDF-1":1,
"carcinome papillaire de la thyroïde":1,
"papillary thyroid carcinoma":51,
"KLK7":1,
"lncRNA-NEAT1":1,
"miR-129-5p":2,
"papillary thyroid cancer":24,
"Geographic locations":1,
"Incidence":7,
"Korea":1,
"Small-Area Analysis":1,
"Biopsy, fine-needle":2,
"Thyroid cancer, papillary":2,
"Thyroid nodule":18,
"Ultrasonography":13,
"Thyroid-like orbitopathy":1,
"complete ophthalmoplegia secondary to metastatic melanoma treatment":1,
"normal extraocular muscles":1,
"ophthalmoplegia with ipilimumab and nivolumab":1,
"Cancer":18,
"Medullary thyroid carcinoma":10,
"Multiple endocrine neoplasia type 2":1,
"Pheochromocytoma":1,
"RET proto-oncogene":3,
"Cancer prevalence":1,
"Italy":1,
"Projections":1,
"Survivors":1,
"Laryngectomy":1,
"Olfactory rehabilitation":1,
"Provox voice prosthesis":1,
"Questionnaire survey":1,
"Self-administered Odor Questionnaire (SAOQ)":1,
"Bone morphogenetic protein 4":1,
"Cell proliferation":3,
"Colony formation":1,
"MicroRNAs":1,
"Thyroid carcinoma":17,
"miR340-5p":1,
"Cytodiagnosis":1,
"Diagnostic imaging":1,
"Fine needle aspiration cytology":2,
"Thyroid neoplasms":18,
"Chinese Han people":1,
"Prevention":1,
"Risk factor":1,
"Vitamin D":1,
"Differentiated thyroid cancer":8,
"Evening sample":1,
"L-T4 posology":1,
"Morning sample":1,
"TSH":4,
"AR":2,
"Breast neoplasm":1,
"Manifestations":1,
"Molecular pathology":1,
"Recurrence":14,
"131I SPECT/CT":1,
"131I planar whole-body scan":1,
"long-term follow-up":1,
"neck and distant metastases":1,
"papillary thyroid microcarcinoma (PTMC)":1,
"serum thyroglobulin":1,
"thyroid/parathyroid":4,
"ultrasound":13,
"Bioinformatics analysis":2,
"Key genes":1,
"Conservative therapy":1,
"Risk management":1,
"Surgery":5,
"Children":2,
"Iodine status":1,
"Pregnant women":1,
"Thyroid volume":1,
"Urine iodine":1,
"Everolimus":2,
"Medullary thyroid cancer":5,
"Neuroendocrine Tumours":1,
"Pasireotide":1,
"American Thyroid Association guidelines":2,
"head and neck":4,
"lymph node surveillance":1,
"pediatrics":3,
"thyroidectomy":13,
"follicular":3,
"intrahepatic cholangiocarcinoma":1,
"papillary":2,
"thyroid neoplasm":7,
"thyroid-like":1,
"SEER":3,
"clinical trial":3,
"outcome":1,
"pan-cancer":1,
"prior cancer":1,
"survival":11,
"MYO1F":1,
"TCO locus":1,
"mitochondrial network":1,
"non-medullary thyroid carcinoma":1,
"whole exome sequencing":1,
"BRAF mutation":3,
"immunocytochemistry":1,
"molecular testing":1,
"plump cells":1,
"thyroid malignancies":1,
"thyroid nodules":11,
"Follicular thyroid cancer":2,
"Great veins invasion":1,
"Internal jugular vein":1,
"Thrombosis":1,
"adolescents and young adults":1,
"disease-specific symptoms":1,
"health-related quality of life":2,
"survivorship":1,
"CT":1,
"lymph node":3,
"metastasis":12,
"differentiated thyroid carcinoma":12,
"iodine-131":3,
"radioactive iodine":6,
"CT: computed tomography":1,
"LDH: lactate dehydrogenase":1,
"Pleural effusion":1,
"TSH: thyroid-stimulating hormone":1,
"TSHoma: thyroid-stimulating hormone (TSH)-secreting pituitary adenoma":1,
"fT4: free thyroxine":1,
"hypothyroidism":6,
"methimazole":1,
"pituitary neoplasms":2,
"neurological monitoring":1,
"residual thyroidectomy":1,
"false-positive":1,
"follicular-pattern lesions":1,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features":3,
"thyroid FNA":1,
"Anti‐CTLA 4":1,
"Anti‐PD1":1,
"Ipilimumab":1,
"Nivolumab":2,
"Pembrolizumab":2,
"Thyroid":32,
"Follicular variant of papillary thyroid carcinoma":3,
"Lymph node metastases":3,
"Ectopic thyroid":3,
"Lingual thyroid":1,
"Papillary carcinoma":3,
"Transoral surgery":1,
"Dilated cardiomyopathy":1,
"Iodide transport defect":1,
"NIS":2,
"RNA splicing":1,
"Thyroid scintigraphy":1,
"hand-foot skin reaction":1,
"overall survival":10,
"sorafenib":6,
"thyroid-stimulating hormone":2,
"thyroxine":2,
"biomarker":5,
"circular RNA":3,
"extrathyroidal extension":4,
"lymph node metastasis":7,
"18F-FDG":1,
"99mTc-sestamibi":1,
"Negative imaging":1,
"Radioiodine":3,
"Rising thyroglobulin":1,
"fish":1,
"5α-dihydrotestosterone supplement":1,
"Estradiol":1,
"Reductive 17β-hydroxysteroid dehydrogenases":1,
"Steroid sulfatase":1,
"ASCL1":1,
"NFIB":1,
"SCLC":1,
"TTF-1":1,
"neuroendocrine differentiation":1,
"Carcinome papillaire thyroïdien":1,
"Carcinome peu différencié":1,
"DICER1":1,
"Poorly differentiated thyroid carcinoma":4,
"Post radiation":1,
"Radiations nucléaires":1,
"Solid variant":1,
"Variante solide":1,
"BC survivors":1,
"Epidemiology, and End Results database":1,
"HR and HER2 subtypes":1,
"Subsequent colorectal and thyroid cancer":1,
"Subsequent ovary/uteri cancer":1,
"Surveillance":3,
"cyclin-dependent kinase":1,
"roniciclib":1,
"well-differentiated thyroid cancer":1,
"lymph node metastasis (LNM)":1,
"papillary thyroid cancer (PTC)":1,
"proteomic analysis":1,
"serum-purified exosomes (SPEs)":1,
"AJCC":1,
"differentiated":1,
"stratification":1,
"active surveillance":5,
"shared decision making":1,
"neoplasia":3,
"obesity":2,
"oncogene":3,
"Biomarkers":1,
"Breast neoplasms":6,
"Thyroid hormone receptor":1,
"Tumor suppressor proteins":1,
"Esophageal squamous cell carcinoma":3,
"Immunohistochemistry":11,
"Tumor necrosis factor receptor 2":1,
"B-mode ultrasonography":1,
"Multi-modality":1,
"Radiomics":2,
"Strain elastography ultrasonography":1,
"B-type Raf (BRAF)":1,
"Hashimoto's thyroiditis":2,
"diffuse lymphocytic infiltration":1,
"thyroid peroxidase antibody":1,
"Breast cancer":17,
"Circulating tumor cells (CTCs)":1,
"Esophageal cancer":1,
"Gastric cancer":4,
"Lung cancer":6,
"Negative enrichment-fluorescence in situ hybridization (NE-FISH)":1,
"CPT1A":1,
"Lymphangiogenesis":1,
"VEGF-C and VEGF-D":1,
"VEGFR-3":1,
"5-Fluorouracil":1,
"Chemoradiotherapy":1,
"Cisplatin":2,
"Docetaxel":1,
"NDAT":1,
"Oral cancer":1,
"PD-L1":2,
"Proliferation":8,
"bioethics":1,
"early detection":1,
"medical imaging":1,
"objectivity":1,
"overdiagnosis":2,
"preventive medicine":1,
"screening":3,
"IL6":1,
"PLX4032":1,
"STAT3":3,
"Tocilizumab":1,
"dosimetry":2,
"lithium":1,
"fine-needle aspiration":8,
"hyperparathyroidism":1,
"washout":1,
"Biologic parameters":1,
"Fatigue":1,
"Quality of life":3,
"Renal cancer":1,
"Sexual disorders":1,
"Gender":1,
"Bone mineral density":2,
"TSH suppression therapy":1,
"Trabecular bone score":1,
"nuclear factor-κB p50":1,
"nuclear factor-κB p65":1,
"quantitative real-time reverse transcription–polymerase chain reaction":1,
"Children and adolescents":2,
"Pulmonary metastases":1,
"Radioactive iodine therapy":2,
"Tumor doubling time":1,
"meta-analysis":12,
"myotonic dystrophy":1,
"nucleotide repeat disorders":1,
"Anti-cancer":1,
"Anti-inflammatory agent":1,
"Docking":1,
"Indicaxanthin":1,
"MM-GBSA":1,
"Molecular dynamics":1,
"Neuromodulator":1,
"Pharmacophore modeling":1,
"Phytochemicals":1,
"Reverse screening":1,
"HORMAD2":1,
"5-aza-2′-deoxycytidine":1,
"DNA methylation":3,
"Body mass index":1,
"early life":1,
"Calcification":1,
"Ectopic pituitary adenoma":1,
"Suprasellar":2,
"TSH-secreting":1,
"Clinical research":1,
"Lenvatinib":10,
"Molecular biology":1,
"Vascular endothelial growth factor":1,
"Adrenal failure":1,
"Diabetes":1,
"Dyslipidemia":1,
"Dysthyroidism":1,
"Hypophysitis":2,
"Immunotherapy":8,
"MTOR inhibitors":1,
"Tyrosine kinase inhibitors":4,
"Antigen":1,
"Cancer survivor":1,
"Immunology":2,
"Pancreatic neoplasm":1,
"Vaccination":1,
"Carcinogen classification":1,
"Follicular thyroid tumors":1,
"Human relevance":1,
"Non-genotoxic chemicals":1,
"Rodent tumors":1,
"Species differences":1,
"Thyroid hormones":2,
"Epidermal growth factor receptor":1,
"Predictive biomarker":1,
"Risk stratification":2,
"β-Catenin":3,
"CD152":1,
"CTLA-4":2,
"Follicular thyroid carcinoma":4,
"Polymorphism":4,
"Single-nucleotide":1,
"rs231775":1,
"rs5742909":1,
"head and neck endocrine surgery":1,
"thyroglossal duct cyst":2,
"Follicular variant papillary thyroid carcinoma":1,
"iodine radioisotopes":3,
"neoplasm recurrence":1,
"therapy":2,
"treatment outcome":1,
"ICAM-1":1,
"miR-335-5p":1,
"miRNAs":1,
"Gynecological risks":1,
"Pregnancy complications":1,
"Reproductive risks":1,
"Thyroid cancer survivors":1,
"Palpation":1,
"Thyroglobulin":5,
"dynamic risk stratification":2,
"prognostic factors":2,
"stimulated postoperative thyroglobulin":1,
"Tc-99m MIBI":1,
"nodules":2,
"side effects":1,
"thyroiditis":1,
"activating TSHR mutation":1,
"goiter":1,
"non-autoimmune hyperthyroidism":1,
"indeterminate cytology":2,
"C-myc":2,
"Liver cancer stem cell":1,
"PKM2":3,
"miR675":1,
"AJCC staging":1,
"age":3,
"fine-needle aspiration cytology":2,
"giant cell tumor":1,
"secondary thyroid neoplasm":1,
"outcomes":4,
"pediatric differentiated thyroid carcinoma":2,
"radioiodine therapy":2,
"Bosniak classification":1,
"Contrast-enhanced ultrasound":1,
"Cystic renal lesions":1,
"Image fusion":1,
"Renal cell carcinoma":6,
"Artemisia annua L":1,
"autophagy":1,
"metastatic renal cell carcinoma":1,
"pyruvate kinase muscle isozyme M2":1,
"AFAP1-AS1":1,
"Carcinogene":1,
"Carcinoma":4,
"Long non-coding RNA":2,
"Invasion":5,
"MAL2":1,
"Migration":4,
"epidermal growth factor receptor (EGFR)":1,
"lung adenocarcinoma":2,
"molecular studies":1,
"non-small cell lung carcinoma (NSCLC)":1,
"prognosis in thyroid transcription factor 1-negative non-small cell lung carcinoma":1,
"thyroid transcription factor 1 (TTF1)":1,
"thyroid transcription factor 1-negative lung adenocarcinoma":1,
"apoptosis":8,
"endoplasmic reticulum stress":1,
"nasopharyngeal carcinoma":3,
"carcinoid cancer":1,
"gastroenteropancreatic":1,
"lutetium Lu 177 dotatate":1,
"neuroendocrine tumors":1,
"fear of recurrence":1,
"population-based":2,
"prospective":1,
"color Doppler ultrasonography":1,
"diagnostic value":1,
"primary hepatic carcinoma":1,
"two-dimensional ultrasonography":1,
"cyclin D2":1,
"microRNA-409-3p":1,
"Chromogenic":1,
"Diagnosis":8,
"Multiplexed immunohistochemistry":1,
"Non-small cell lung cancer":4,
"Predictive biomarkers":1,
"Roux-en-Y reconstruction":1,
"distal jejunal pouch":1,
"total gastrectomy":1,
"Granular cell tumours of the neurohypophysis":1,
"Pituicytoma":1,
"Posterior pituitary tumours":1,
"Spindle cell oncocytoma":2,
"Aggressiveness":2,
"Cell adhesion":1,
"Papillary thyroid microcarcinoma":7,
"Somatic mutation":1,
"Whole-exome sequencing":2,
"EMT":2,
"FGF signaling":1,
"TKI":1,
"Thyroid malignancy":1,
"bilateral surgery":1,
"intraoperative neuromonitoring":1,
"invaded nerve":1,
"nerve preservation":1,
"nerve resection":1,
"only functional nerve":1,
"recurrent laryngeal nerve":2,
"thyroid surgery":2,
"vocal cord paralysis":1,
"Hippo":1,
"LATS":1,
"MOB1":1,
"NF2":2,
"Rho":1,
"YAP":2,
"phosphatidic acid":1,
"phospholipase D":1,
"C-cell":1,
"familial":1,
"medullary":2,
"sporadic":1,
"Dual malignancy":1,
"liver":1,
"mucosa-associated lymphoid tissue lymphoma":1,
"Incidental":2,
"Non-incidental":1,
"Modified radical neck dissection":1,
"cytology":4,
"I-131":1,
"scintigraphy":1,
"SPECT/CT":1,
"AFF3":1,
"Estrogen receptor-positive":1,
"Resistance":1,
"Tamoxifen":1,
"cohort studies":1,
"risk":1,
"sociodemographic":1,
"CXCL5":1,
"NKX2-1":1,
"SOX2":2,
"adenocarcinoma":1,
"mouse models":2,
"squamous":1,
"transdifferentiation":1,
"tumor immune microenvironment":1,
"tumor-associated neutrophils":1,
"biopsy":1,
"fine-needle aspiration (FNA)":1,
"Assodium/iodide symporter":1,
"Mitogen-activated protein kinase":1,
"Mutation BRAFV600E":1,
"Fine needle aspiration":5,
"Molecular marker":1,
"Proprotein convertase PACE4":1,
"B-Raf proto-oncogene":1,
"Gray-scale ultrasound":1,
"Level VI lymph nodes":1,
"Shear wave elastography":1,
"connective tissue disease":1,
"malignant and benign haematology":1,
"Gene therapy":1,
"Sodium iodide symporter":1,
"Theranostics":1,
"18F-FDG PET/CT":2,
"Axillary lymph node metastasis":1,
"Hürthle cell carcinoma of the thyroid":1,
"VEGF":1,
"antiangiogenesis":1,
"hypertension":1,
"osteopenia":1,
"postmenopausal women":1,
"thyroid-stimulating hormone suppression":1,
"The Cancer Genome Atlas":4,
"long noncoding RNAs":3,
"risk score":2,
"comparative genomics":1,
"flow sorting":1,
"intratumoral heterogeneity":1,
"metastatic tumor evolution":1,
"Anaplastic thyroid Cancer":6,
"Inhibitors":1,
"Therapeutics":1,
"Tumor":1,
"Hashinoto's disease":1,
"anti-thyroid antibodies":1,
"neck dissection":3,
"spinal accessory nerve":1,
"Cachexia":1,
"Exosomes":1,
"Tumour progression":1,
"Big data":1,
"Decision support system":1,
"Evidence based medicine":1,
"Forecasting":1,
"Genomics":1,
"Guidelines":3,
"Head and neck cancer":6,
"Machine learning":1,
"Oncology":5,
"Radiotherapy":5,
"Support vector machine":1,
"HCC":2,
"NASH":1,
"epidemiology":5,
"physiopathology":1,
"interobserver variation":1,
"risk of malignancy":1,
"sonography":1,
"Incidental carcinoma":1,
"Multiple endocrine neoplasia 2A":1,
"Prophylactic thyroidectomy":1,
"Recurrent carcinoma":1,
"Suture granuloma":1,
"HBXIP":2,
"miR-145":1,
"Thyroid micronodules":1,
"malignancy":5,
"elastography":2,
"strain index":2,
"Fluorodeoxyglucose positron emission tomography":1,
"histopathology report":1,
"intrathyroid metastasis":1,
"squamous cell carcinoma":1,
"Adrenal oncocytoma":1,
"fluorodeoxyglucose":1,
"magnetic resonance imaging":4,
"positron emission tomography/computed tomography":1,
"radioiodine scan":1,
"skeletal metastasis":1,
"Classification":1,
"Next generation sequencing":2,
"RNA sequencing":1,
"Anaplastic thyroid carcinoma":4,
"Bioinformatics":1,
"Cancer/testis gene":1,
"Chromosome segregation":1,
"Key genes identification":1,
"Meta-analysis of microarray datasets":1,
"Adverse effect":1,
"Benign Prostatic Hyperplasia":1,
"Prostate":1,
"Adverse events":1,
"anti-PD-1 antibody":1,
"dysphagia":1,
"parathyroidectomy":1,
"CASTLE":1,
"extrathyroidal tumor extension":1,
"thyroid tumor":2,
"IGFBP5":1,
"UCA1":1,
"lncRNA":1,
"miR-204":1,
"calcitonin":6,
"calcium gluconate":1,
"pentagastrin":1,
"ROS1 rearrangement":1,
"carcinoma of unknown primary site":1,
"crizotinib":1,
"putative lung adenocarcinoma":1,
"Mandible":1,
"Maxilla":1,
"Microvascular reconstruction":1,
"Osseous reconstruction":1,
"ECLIA":1,
"Electrochemiluminescence immunoassay":1,
"Fine-needle aspiration washout fluid":1,
"Influencing factors":1,
"Matched case-control study":1,
"Ethanol ablation":1,
"Radiofrequency ablation":3,
"MTDH":1,
"lobaplatin":1,
"BRAF":6,
"Malignant papillary thyroid carcinoma":1,
"Struma ovarii":1,
"CN = cranial nerve":1,
"CNS = central nervous system":1,
"EMA = epithelial membrane antigen":1,
"GFAP = glial fibrillary acidic protein":1,
"GTR = gross-total resection":1,
"OSH = outside hospital":1,
"S100 = S100 protein":1,
"SCO = spindle cell oncocytoma":1,
"TS = transsphenoidal":1,
"TTF-1 = thyroid transcription factor 1":1,
"WHO = World Health Organization":1,
"neurosurgery":1,
"pituitary surgery":2,
"transsphenoidal":1,
"Branchial cleft cysts":1,
"congenital defect":1,
"fine-needle biopsy":2,
"Antituberculous therapy":1,
"Clinical presentation":1,
"Granulomatous lobular mastitis":1,
"Management":1,
"Completion thyroidectomy":2,
"postoperative complication":1,
"Neoadjuvant chemotherapy":2,
"Preoperative circulating neutrophil–lymphocyte ratio":1,
"Primary bladder cancer":1,
"Radical cystectomy":1,
"Unfavorable outcome":1,
"time until recurrence of the disease":1,
"EQ5D":1,
"cancer site":1,
"cancer survivors":1,
"BRAF V600E gene":1,
"pathological examination":1,
"lymphatic metastasis":3,
"piriform fossa cancer":1,
"postoperative pharyngeal fistula":1,
"thyroid lobes":1,
"Chernobyl":1,
"radiation":3,
"radioactivity":1,
"surveys and questionnaires":1,
"Graves’ disease":2,
"Marine‐Lenhart syndrome":1,
"hot thyroid nodule":1,
"EGFR":2,
"HPV":1,
"P16":1,
"accelerated":1,
"cyclin D1":2,
"genetics":3,
"hyperfractionated":1,
"radiation therapy":2,
"translational research":1,
"Lifetime risk":1,
"medulloblastoma":1,
"pediatric patients":1,
"secondary cancer":1,
"Diffusion-weighted imaging":1,
"diffusion-weighted whole-body imaging with background body signal suppression":1,
"imaging":1,
"obstetrics":1,
"pregnancy":2,
"NMR-based metabolomics":1,
"CEA":1,
"Calcitonin doubling time":1,
"Multiple endocrine neoplasia":3,
"MEN":1,
"head and neck neoplasms":1,
"marginal zone B-cell lymphoma":1,
"mucosa-associated lymphoid tissue":1,
"histopathology":1,
"neuroendocrine markers":1,
"pathologic diagnosis":1,
"T-cadherin":1,
"locally advanced breast cancer":1,
"Câncer de tireoide":1,
"Microcarcinoma":3,
"Tireoidite de Hashimoto":1,
"cohort study":1,
"ionizing radiation":1,
"occupational exposure":2,
"radiologic technologists":1,
"AICAR":1,
"CXCL8":1,
"Chemokines":1,
"Breast microcalcification":1,
"Core needle biopsy":3,
"Vacuum-assisted biopsy":1,
"Latero-cervical lymph node metastases":1,
"Thyroid cancer metastases":1,
"Thyroid cancer outcome":1,
"Thyroid cancer-related mortality":1,
"99mTc-MIBI scintigraphy":1,
"BRAFV600E":1,
"Bio-chemical incomplete response":1,
"Metastatic thyroid cancer":1,
"Lymph node dissection":1,
"Papillary thyroid carcinoma (PTC)":4,
"Right paraesophageal lymph node":1,
"Carcinoma arising from thyroglossal duct cyst":1,
"Cystic squamous cell carcinoma":1,
"HPV-related squamous cell carcinoma":1,
"p16 immunohistochemistry":1,
"Shear wave":1,
"diagnostic efficacy":1,
"invasive techniques":1,
"computer-assisted":1,
"informatics/image processing":1,
"lymph nodes":3,
"pattern recognition":1,
"Breast carcinoma metastatic":1,
"GATA3":1,
"carcinoma, thyroid":1,
"positive margin":1,
"EZH1":1,
"Molecular diagnostics":2,
"RAS genes":1,
"TERT":3,
"endoscopic":1,
"submental":1,
"transoral":1,
"spectral CT imaging":1,
"tomography":1,
"Lactotrope":1,
"Menin":1,
"Pituitary":1,
"Prolactinoma":1,
"Ral":1,
"Ras":1,
"Primary medullary thyroid carcinoma":1,
"Tumour staging":1,
"[18F]DOPA PET/CT":1,
"Biopsy, large-core needle":1,
"bone growth":1,
"puberty":1,
"Clinical practice":1,
"Mutation":3,
"acute pancreatitis":1,
"autoimmune thyroiditis":2,
"gonadotropin-releasing hormone agonist":1,
"myxedema coma":1,
"TNRC6C-AS1":1,
"UNC5B":1,
"FTIR":1,
"Follicular thyroid carcinoma (FTC)":1,
"PCA":1,
"MCF-7 cell":1,
"Notch signaling pathway":1,
"T47D cell":1,
"radiosensitivity":2,
"MEN1":1,
"Multiple endocrine neoplasia type 1":1,
"Parathyroid carcinoma":2,
"Primary hyperparathyroidism":2,
"Primary tumor size":1,
"Hepatocellular carcinoma":5,
"SSR3":1,
"Survival analysis":3,
"GLI1":1,
"GLI2":1,
"SHH":1,
"Hook1":1,
"Immunochemistry":2,
"SHP2":1,
"Biphenotypic":1,
"Collision tumor":1,
"Composite tumor":1,
"Next-generation sequencing":2,
"Tumor-to-tumor metastasis":1,
"Gamma-probe technique":1,
"Lymphoscintigraphy":1,
"Sentinel lymph node biopsy":1,
"Vital blue dye technique":1,
"differentially expressed genes":2,
"differentially expressed long non-coding RNAs":1,
"progression":1,
"PINX1":1,
"Prognostic marker":1,
"Lymphocyte-to-monocyte ratio":1,
"Chromophobe renal cell carcinoma":1,
"Xanthogranulomatous pyelonephritis":1,
"Mortality":1,
"Sex differences":2,
"Trends":1,
"Graves' disease":2,
"Electrophoresis":1,
"mass spectrometry":1,
"proteomics":3,
"serum":2,
"bioinformatical analysis":1,
"hub genes":1,
"methylation":1,
"pathways":1,
"thyroid cancer (THCA)":1,
"IGF-1 receptor":1,
"folliculogenesis":1,
"hyperplasia":2,
"insulin receptor":1,
"Microwave":2,
"Euthyroid nodular goiter":1,
"Insulin resistance":1,
"Pulse wave velocity":1,
"Subtype":1,
"Hemianopsia":1,
"Pituitary adenomas":1,
"BRAF(V600E) mutation":1,
"CK19":2,
"Central cervical lymph node metastases":1,
"Galectin-3":1,
"Human bone marrow endothelial cell-1":1,
"Thyroid peroxidase":1,
"propensity score matching":1,
"telomerase":1,
"telomerase reverse transcriptase (TERT) promoter mutation":1,
"transcriptome":2,
"Iodine":2,
"Perchlorate":1,
"Thiocyanate":1,
"Urine":1,
"BRAFV600E mutation":1,
"epithelial mesenchymal transition":1,
"microRNA-150-5p":1,
"anlotinib":1,
"Central compartment":1,
"Level VI":1,
"Radiation dosimetry":1,
"Radiation risk":1,
"Therapeutic NM":1,
"Lobectomy":3,
"Systematic review":3,
"Total thyroidectomy":4,
"Akt-mTOR pathway":1,
"PDPK1":1,
"miR-718":1,
"Chemosensitivity":1,
"Dauricine":1,
"Glycolysis":1,
"MiR-199a":1,
"Ki-67":1,
"Lipocalin-2 (Lcn2)":1,
"NFκB":1,
"Pediatric thyroid cancer":1,
"Glycol chitosan":1,
"doxorubicin⋅hydrochloride":1,
"local drug delivery system":1,
"visible light irradiation":1,
"Cancer registries":1,
"Cancer survival":1,
"Excess mortality":1,
"Inequalities":1,
"Schisandrin B":1,
"Triple negative breast cancer":1,
"Clinicopathological characteristic":1,
"Northwest China":1,
"retrospective study":1,
"oncocytic variant papillary thyroid carcinoma":1,
"circulating epithelial cells":1,
"epithelial cell adhesion molecule":1,
"podoplanin":1,
"benign thyroid nodule":1,
"initial ablation ratio":1,
"therapeutic success":1,
"thermal ablation":2,
"computed tomography":2,
"persistent":1,
"gene expression profiling":1,
"massively parallel sequencing":1,
"molecular profile":1,
"radioiodine-refractory thyroid carcinoma":1,
"refractory":1,
"Approach":1,
"Survey":1,
"Natural killer cell":1,
"PD-1":2,
"Tim-3":1,
"Circulating tumour DNA":1,
"Personalised medicine":1,
"Complex structure":1,
"Growth inhibition":1,
"IL-1RAcP":1,
"Triple-negative breast cancer":1,
"scFv 12H7":1,
"Combination effect":1,
"Nanoparticles":1,
"Selenium":1,
"X-ray":1,
"ORPH":1,
"Tumor growth":1,
"miR-491-5p":1,
"radioiodine refractoriness":1,
"risk factors":5,
"scoring system":1,
"Hashimoto's encephalopathy":1,
"MRI":1,
"Parkinsonism":1,
"Pathology":4,
"SREAT":1,
"Tumor-like lesions":1,
"GPER1":1,
"Shenmai injection":1,
"Treg cells":1,
"miR-103":1,
"Cribado":1,
"Cáncer de mama":1,
"Cáncer de próstata":1,
"Cáncer de tiroides":1,
"Incidentaloma":1,
"Incidentalomas":1,
"Prostate cancer":1,
"Sobrediagnóstico":1,
"BRAFv600e test":1,
"FNA-Tg":1,
"FNAC":1,
"C-reactive protein":1,
"Recurrence-free survival":1,
"branchial cleft cyst":1,
"neck":1,
"thyroid pathology":1,
"Hürthle cell carcinoma (HCC)":1,
"close homolog of L1 (CHL1)":1,
"prognostic biomarker":1,
"whole-transcriptome sequencing":1,
"thyroid imaging reporting and data system":1,
"LRIG1":1,
"TTF-1/Nkx2 1":1,
"needle biopsy clinic":1,
"review":2,
"technique":1,
"thyroid nodule/diagnostic imaging":1,
"Antagonistes de la vitamine K":1,
"Cancer du poumon non à petites cellules":1,
"Hyperthyroidism":3,
"Hémorragie":1,
"Immune related adverse event":1,
"Immunothérapie":1,
"Vitamin K antagonists":1,
"Évènement indésirable grave":1,
"competing endogenous RNAs network":1,
"Contralateral central lymph node metastasis":1,
"TSG101":1,
"anoikis resistance":1,
"complication":1,
"cosmetic":1,
"endoscopic thyroidectomy with central neck dissection":1,
"transoral vestibular approach":1,
"LATS1":1,
"LINC01186":1,
"YAP1":1,
"long noncoding RNA":1,
"collagen":2,
"extracellular matrix":2,
"signaling pathways":1,
"inherited cancer susceptibility":1,
"multiple primary malignant tumors":1,
"mutation profiling":1,
"synchronous carcinoma":1,
"CD56":1,
"Gal-3":1,
"HBME-1":1,
"NIFTP":5,
"follicular variant":1,
"EWSR1 gene":1,
"NR4A3 gene":1,
"extraskeletal myxoid chondrosarcoma":1,
"fluorescence in situ hybridization":1,
"Afirma":1,
"Rosetta Reveal":1,
"gene expression classifier":1,
"indeterminate thyroid cytology":1,
"miRNA classifier in":1,
"endoscopic ultrasound":1,
"liquid-based cytology":2,
"pancreatic metastasis":2,
"small-cell carcinoma":1,
"Molecular-targeting therapy":1,
"Multikinase inhibitor":1,
"Radioactive iodine refractory":1,
"IRF-1":1,
"Metformin":2,
"Verteporfin":1,
"microRNA (miRNA)":1,
"Anti-thyroglobulin":1,
"Cystathione β-synthase":1,
"NAMPT":1,
"follicular adenoma":1,
"follicular carcinoma":1,
"AKT":2,
"chemotherapeutic agent":1,
"evodiamine":1,
"synergism":1,
"Renal transplantation":1,
"South Korea":1,
"dose threshold":1,
"dose-volume parameters":1,
"intensity-modulated radiotherapy":1,
"Artery-first approach":1,
"Borderline resectable pancreatic cancer":1,
"Conventional approach":1,
"Mesenteric approach":1,
"Pancreatic ductal adenocarcinoma":1,
"Pancreaticoduodenectomy":1,
"R0 resection":1,
"Resectable pancreatic cancer":1,
"Superior mesenteric artery":1,
"TNM staging":3,
"Adrenal tumors":1,
"Adrenalectomy":1,
"Adrenocortical carcinoma (ACC)":1,
"Case report":3,
"Hormone secretion":1,
"Nonfunctioning":1,
"Gene":1,
"Tumor stage":1,
"miRNA":2,
"Epithelial-mesenchymal transition":1,
"Fibroblast activation protein alpha":1,
"Peritoneal metastasis":1,
"Genetic feature":1,
"Melanin":1,
"CTNNBIP1":1,
"Wnt/β-catenin":1,
"circRNA_102171":1,
"CCND1":1,
"CCND1b":1,
"cyclin D1b":1,
"131I radiotherapy":1,
"SNPs":1,
"toxicity reactions":1,
"Hormone replacement therapy":1,
"Hypothalamic hypopituitarism":1,
"Pan-hypopituitarism":1,
"Recessus infundibuli":1,
"Small cell lung cancer":1,
"Burkitt’s lymphoma":1,
"Thyroid lymphomas":1,
"Iran":1,
"Registry":1,
"Fine-needle aspiration biopsy":2,
"RNA":2,
"RNA integrity number":1,
"Papillary thyroid":1,
"miR-146b":1,
"miR-21":1,
"microRNA":2,
"hypercalcemia":1,
"Drugs":1,
"Metabolic":1,
"MET":1,
"PI3K/AKT":1,
"XIST":1,
"miR-34a":1,
"INPPL1 expression":1,
"Chemistry":1,
"Molecular Genetics":1,
"Cardiac function":1,
"Myocardial perfusion":1,
"Suppression time":1,
"Thyroid stimulating hormone":1,
"Fluorescence imaging":1,
"γ-glutamyl hydroxymethyl rhodamine green":1,
"γ-glutamyltranspeptidase":1,
"Ablation techniques":1,
"NADP":1,
"Succinate dehydrogenase":1,
"Breast cancer stem cells":1,
"E2F1":1,
"LINC00511":1,
"Nanog":1,
"miR-185-3p":1,
"Cowden’s syndrome":1,
"Mucocutaneous manifestations":1,
"PTEN hamartoma tumor syndrome":1,
"Metabolomics":1,
"Multinodular goiter":1,
"NMR":1,
"Lentivirus":1,
"Neoplasm metastasis":3,
"Rhomboid domain - containing 1":1,
"Small interfering":1,
"diabetes mellitus":1,
"gestational diabetes mellitus":1,
"FokI polymorphism":1,
"VDR gene":1,
"Clinicopathological predictors":1,
"Disease-free survival":1,
"Sorting nexin 10":1,
"Stomach adenocarcinoma":1,
"Weighted gene co-expression network analysis":1,
"Endocrine":1,
"Oncology: Endocrine":1,
"radioiodine treatment":1,
"salivary gland dysfunction":1,
"xerostomia":1,
"Basal cell carcinoma":1,
"Chronic lymphocytic leukemia":1,
"Second primary cancer":1,
"IR-A/IGF2 autocrine loop":1,
"hybrids receptors":1,
"insulin receptor isoforms":1,
"insulin/IGF system":1,
"thyroid cancer stem cells":1,
"localized drug delivery":1,
"matrix metalloproteinase":1,
"tumor extracellular matrix":1,
"tumor penetration":1,
"Proteinuria":2,
"Radioactive iodine- refractory differentiated thyroid cancer":1,
"Thrombotic microangiopathy":1,
"Hürthle cell adenoma":1,
"papillary cell carcinoma":1,
"Chemotherapy":1,
"Locoregional recurrence":1,
"Lymph nodes metastasis":2,
"Treatment strategy":1,
"Trichilemmal carcinoma":1,
"BRAF inhibition":1,
"Cancer therapy":1,
"MEK inhibition":1,
"Multikinase inhibitors":1,
"Selective kinase inhibitors":1,
"Targeted drugs":1,
"Tracheal invasion":1,
"Well-differentiated thyroid carcinoma (DTC)":1,
"ear, nose and throat/otolaryngology":1,
"head and neck surgery":1,
"otolaryngology / ENT":1,
"surgical oncology":1,
"Cabozantinib":2,
"Chronic kidney failure":1,
"Renal adverse events":1,
"Tyrosine kinase inhibitor":3,
"Disease recurrence":1,
"Survival rate":1,
"Thyroglobulin level":1,
"medical expertise of interdependence of diseases bring to disability and death with the effect of the consequences of the Chornobyl accident":1,
"radiation exposure":2,
"victims of the accident at the Chornobyl Nuclear Power Plant":1,
"Inflammation":1,
"Neutrophil-to-lymphocyte ratio":1,
"CLDN10":1,
"PTC":4,
"tumorigenesis":2,
"Parathyroid cyst":1,
"genistein":1,
"HGF":1,
"S100A11":1,
"DTC":1,
"brain metastases":1,
"prevalence":2,
"therapies":1,
"Benign pathologies":1,
"TENIS syndrome":1,
"metastatic sites":1,
"radio iodine":1,
"whole body 131I scan":1,
"Atypia of undetermined significance”/”follicular lesion of uncertain significance":1,
"BRAF mutations":1,
"Anaplastic":2,
"Cancer disparities":1,
"Clinical trial enrollment":1,
"Endocrine cancer":1,
"Health disparities":1,
"Parity":1,
"South Africa":1,
"iodine negative":1,
"liver surgery":1,
"MCM3":1,
"MCM7":1,
"Salivary adenoid cystic carcinoma":1,
"CTNNB1/Wnt pathway":1,
"Cribriform morular variant":1,
"Familial adenomatosis polyposis":1,
"LEF-1":1,
"Hybrid procedure":1,
"Lung tumor":1,
"Mediastinal tumor":1,
"Robotic surgery":1,
"Single incision":1,
"Alexis retractor":1,
"Retractor":1,
"lateral orbit":1,
"thyroid eye disease":1,
"Extramedullary hematopoiesis":1,
"post-progression survival":1,
"progression-free survival":1,
"signal transducers activators of transcription":1,
"Pseudoinclusions":1,
"Ubiquitin":1,
"Adults":1,
"Influences":1,
"Age distribution":1,
"Aging society":1,
"Nationwide inpatient database":1,
"Otolaryngological surgery":1,
"Hepatocarcinoma":1,
"SK-hep1 cells":1,
"TRβ1":1,
"Tumor suppressor":1,
"Ablation":1,
"Non-vascular interventions":1,
"FN1":1,
"Quantitative proteomics":1,
"RPS6KA3":1,
"Sporadic medullary thyroid cancer":1,
"Tandem mass tag":1,
"Advanced thyroid cancer":1,
"Central neck dissection":1,
"Hypoparathyroidism":1,
"Parathyroid gland":1,
"Chest-breast approach":1,
"Endoscopic surgery":1,
"Radionuclide imaging":1,
"Radioactive iodine-refractory differentiated thyroid cancer":1,
"Renal impairment":1,
"Hypothalamic-pituitary axis":1,
"Prolactin":1,
"TRH stimulation assay":1,
"Thyroid disorders":2,
"Thyrotropin-releasing hormone":1,
"18-Fluorodeoxyglucose positron-emission tomography/computed tomography":1,
"Endoscopic ultrasound-guided fine-needle aspiration biopsy":1,
"Electronic health records":1,
"Genetic counseling":1,
"Standard of care":1,
"Creatine kinase":1,
"Thyroid FNA anticoagulation":1,
"Thyroid FNA bleeding":1,
"Thyroid FNA haematoma":1,
"endometriosis":1,
"mouth cancer":1,
"pancreatic cancer":1,
"diagnostic":1,
"Lumbar spine":1,
"Metastatic tumors":1,
"Surgical approach":1,
"Total en bloc spondylectomy":1,
"Parathyroid":2,
"Solid cell nest":1,
"Ultimobranchial body":1,
"physical function":1,
"physiotherapy":1,
"rehabilitation":1,
"Differential diagnosis":1,
"Gene mutations":1,
"Structural disease":1,
"Monte Carlo dosimetry":1,
"phantom model":1,
"pathologist practice":1,
"thyroid cancers":1,
"thyroid epidemiology":1,
"Metastatic lymph node":1,
"Anticancer":1,
"Hypericin":1,
"Photodynamic therapy":1,
"ROS":1,
"COSMIC":1,
"Mutations":1,
"Hashimoto thyroiditis":2,
"Programmed&nbsp":1,
"death-ligand 1":1,
"ABC transporters":1,
"cisplatin resistance":1,
"human ovarian cancer":1,
"millepachine":1,
"xenograft models":1,
"Histone deacetylase inhibitors":1,
"Sodium butyrate":1,
"Valproic acid":1,
"Somatostatin receptor 2A":1,
"Tissue microarray":1,
"clonal evolution":1,
"exome sequencing":1,
"well-differentiated thyroid carcinoma":2,
"zebrafish":1,
"Response":1,
"HBME1":1,
"Neoplasm":1,
"Non-invasive":1,
"anti-Müllerian hormone":1,
"ovarian reserve":1,
"radioiodine ablative therapy":1,
"I-IONM":1,
"Neuromonitoring":1,
"Recurrent laryngeal nerve stimulation":1,
"Staged thyroidectomy":1,
"Thyroid lobectomy":1,
"Clinical follow-up":1,
"Non-invasive thyroid neoplasm with papillary-like nuclear features (NIFTP)":1,
"Immunoassay":1,
"Needle-wash thyroglobulin":1,
"Intrathyroid thymic carcinoma":1,
"Monoclonal PAX8":1,
"HMGA2":1,
"Cirugía general":1,
"General surgery":1,
"Imágenes de resonancia magnética":1,
"Nódulo tiroideo":2,
"MLN8237":1,
"antitumor effect":1,
"aurora A kinase":1,
"tumor volume":1,
"Growth":2,
"NR4A3":1,
"endocrine surgery outcomes":1,
"robotic thyroidectomy":1,
"transaxillary thyroidectomy":1,
"Hobnail variant":1,
"Hürthle cell carcinoma":1,
"Tall cell variant":1,
"Bethesda system":2,
"cell block":1,
"conventional smear":1,
"Immune checkpoint inhibitors":1,
"FOXO1":1,
"PI3K":2,
"Mitotic slippage":1,
"Exposure–response modeling":1,
"Radioiodine-refractory":2,
"miR-146b-3p":1,
"miR-146b-5p":1,
"Birthweight":1,
"Childhood cancer":1,
"Mediation analysis":1,
"Sex-disparity":1,
"PI3K/Akt pathway":1,
"TEKT4":1,
"adrenal gland neoplasms":1,
"pancreatic neoplasms":1,
"primate":1,
"MRC 65/93":1,
"antithyroglobulin antibodies":1,
"immunoassays":1,
"Atipia de significado indeterminado (AUS)/lesión de significado indeterminado (FLUS)":1,
"Atypia of undetermined significance (AUS)/follicular lesion of undetermined significance (FLUS)":1,
"Bethesda classification":1,
"Clasificación de Bethesda":1,
"Punción-aspiración con aguja fina":1,
"Sp1":1,
"ZEB1":1,
"false-negative rates":1,
"malignancy rates":1,
"observation":1,
"surgical resection":1,
"ultrasound size":1,
"Pediatric surgery":1,
"Supplementary resection":1,
"Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":2,
"Extent of resection":1,
"Low-grade glioma":1,
"Seizure outcome":1,
"Updated molecular genetics":1,
"menopause":1,
"Cross-sectional studies":1,
"General practice":1,
"Health services research":1,
"Otolaryngologists":1,
"Thyroid gland":2,
"Advances":1,
"Decade":1,
"Cytodiagnostic clues":1,
"Follicular variant of papillary thyroid carcinoma (FVPTC)":1,
"indeterminate thyroid nodule":1,
"molecular classifier":1,
"precision endocrinology":1,
"Low risk thyroid cancer":1,
"Micro carcinoma":1,
"Breast":1,
"Contouring":1,
"Delineation":1,
"Délinéation":1,
"Organe à risque":1,
"Organs at risk":1,
"Sein":1,
"Target volumes":1,
"Temps de travail":1,
"Volume cible":1,
"Worktime":1,
"Lynch syndrome":1,
"hereditary nonpolyposis colorectal cancer (HNPCC)":1,
"Hyposalivation":1,
"radiology report":1,
"ERα":1,
"STAT1":1,
"transcription":1,
"C-PTC":1,
"FV-PTC":1,
"classic papillary thyroid carcinoma":1,
"aggressive":1,
"tall cell":1,
"tall cell feature":1,
"cutaneous infantile hemangioma":1,
"propranolol":1,
"subsequent malignant neoplasms":1,
"cribriform-morular variant of papillary thyroid carcinoma":1,
"lung":2,
"Cancer du sein":1,
"Cancer recurrence":1,
"Cancer risk":1,
"Clinical guidelines":1,
"Contraception":1,
"Contraception after cancer":1,
"Contraception après cancer":1,
"Recommandations":1,
"Risque de cancer":1,
"Récidive de cancer":1,
"Formalin fixation conditions":1,
"Gastric adenocarcinoma":1,
"HER2 status":1,
"Re-biopsy":1,
"Trastuzumab":2,
"Extracellular vesicles":1,
"Glioblastoma":1,
"IL-15":1,
"NK cells":1,
"Tumor targeting":1,
"carcinogenesis":1,
"iodothyronine deiodinases":1,
"mRNA stability":1,
"non-coding RNA":1,
"thyroid hormone":1,
"tumor-initiating cell":1,
"India":1,
"Pyrosequencing":1,
"Thyroid tumors":1,
"Laparoscopic TME":1,
"Pathological outcome":1,
"Perioperative":1,
"Result meta-analysis":1,
"TaTME":1,
"Degradation in&nbsp":1,
"vitro":1,
"Degradation simulation formula":1,
"Preanalytical phase":1,
"circNUP214":1,
"Fluorescence imaging system":1,
"Indocyanine green":1,
"Postoperative parathyroidism":1,
"malignant genitourinary tract tumor":1,
"renal neoplasm":1,
"BRAF V600E mutation":1,
"Integrins":1,
"Osteopontin":1,
"liver cancer":1,
"orthotopic liver transplantation":1,
"Gross total resection":1,
"Hypopituitarism":1,
"Invasive pituitary adenoma":1,
"Radiographic classification":1,
"Relapse":1,
"Chronic lymphocytic thyroiditis":1,
"Hashimoto’s thyroiditis":1,
"Diagnostic disparities in thyroid gland lesions":1,
"Differentiated and dedifferentiated thyroid gland cancers":1,
"Metastasis in thyroid cancers":1,
"Survival in thyroid gland cancers":1,
"Thyroid gland malignancies":1,
"Carbon nanoparticles":1,
"Parathyroid glands":1,
"hub gene":1,
"novel lncRNA-miRNA-mRNA network":1,
"second primary malignancy":1,
"synchronous cancer":1,
"miR-146a":1,
"susceptibility":2,
"Brn-3α":1,
"ER":1,
"TRIM16":1,
"Coxsackie adenovirus receptor":1,
"DNA methyltransferase":1,
"HDAC":1,
"epigenetic treatment":1,
"sodium iodide co-transporter":1,
"Heparin":1,
"protamine":1,
"Augmented reality":1,
"Computed-assisted surgery":1,
"Robotic surgical procedures":1,
"Diffusion weighted imaging":1,
"BRAF V600E":1,
"Matrix metalloproteinase-9":1,
"Childhood cancer survivors":1,
"Haemangioma":1,
"Secondary thyroid cancer":1,
"CXCL10":2,
"Cytokines":1,
"Hydrogen peroxide":1,
"Myo-inositol":1,
"Selenomethionine":1,
"Thyrocytes":1,
"Aged":1,
"Neoplasm recurrence, local":1,
"Medical radiation workers":1,
"Risk assessment":1,
"Reconstruction of the chest wall":1,
"Sternal tumor":1,
"Titanium sternal fixation system":1,
"Comprehensive neck dissection":1,
"Selective neck dissection":1,
"Adjuvant therapy":1,
"AJCC TNM staging system":1,
"Prediction":1,
"Small thyroid nodules":1,
"TI-RADS classification":1,
"Ultrasound elastography":1,
"Medullary carcinoma thyroid":1,
"Not otherwise specified (NOS)":1,
"Triple thyroid tumor":1,
"Atypical metastasis":1,
"Breast metastases":1,
"Thyroid metastases":2,
"Co-expression network analysis":1,
"SYPL1":1,
"THAP1":1,
"short coiled-coil protein":1,
"Basement membrane":1,
"laminin":1,
"Cytokeratin 7":1,
"prognostic factor":2,
"thyroid transcription factor-1":1,
"Hsa_circ_0060060":1,
"miR-144-3p":1,
"ACTH = adrenocorticotropic hormone":2,
"AMI = Auditory Memory Index":1,
"Cushing’s":1,
"D-KEFS = Delis-Kaplan Executive Function System":1,
"DMI = Delayed Memory Index":1,
"FSIQ = Full Scale Intelligence Quotient":1,
"GH = growth hormone":2,
"GKRS = Gamma Knife radiosurgery":1,
"IMI = Immediate Memory Index":1,
"NFA = nonfunctioning adenoma":1,
"SHBG = sex hormone–binding globulin":1,
"T4 = thyroxine":1,
"TSH = thyroid-stimulating hormone":2,
"VMI = Visual Memory Index":1,
"VWMI = Visual Working Memory Index":1,
"WAIS-IV = Wechsler Adult Intelligence Scale–Fourth Edition":1,
"WMS-IV = Wechsler Memory Scale–Fourth Edition":1,
"cognitive function":1,
"memory":1,
"nonfunctioning adenoma":1,
"stereotactic radiosurgery":1,
"de-differentiation":1,
"miR-19a":1,
"liposome":1,
"miR-34b":1,
"Microgravity":1,
"cytoskeleton":1,
"focal adhesion":1,
"hypergravity":1,
"random positioning machine":1,
"sounding rocket":1,
"Revised Tokuhashi score":1,
"Spinal metastasis":1,
"epithelial-to-mesenchymal":1,
"PIK3CA":1,
"fertility":1,
"laparoscopic surgery":1,
"mature cystic teratoma":1,
"reproductive age":1,
"let7a-2":1,
"micro-RNA (miRNAs)":1,
"pri-mir-34b/c":1,
"5-ALA = 5-aminolevulinic acid":1,
"EPR = enhanced permeability and retention":1,
"FRα = folate receptor–alpha":1,
"ICG = indocyanine green":1,
"NIR = near-infrared":1,
"NPV = negative predictive value":1,
"PPV = positive predictive value":1,
"SBR = signal-to-background ratio":1,
"SPECT = single-photon emission computed tomography":1,
"SWIG = second-window ICG":1,
"folate receptor":1,
"indocyanine-green":1,
"near-infrared imaging":1,
"pituitary adenoma":1,
"targeted imaging":1,
"Cancer-specific survival":1,
"Estrogen receptor":1,
"Male breast cancer":1,
"Progesterone receptor":1,
"SLC7A11":1,
"SLC7A3":1,
"SLC7A5":1,
"drug reactions":1,
"ectopic hyperthyroidism":1,
"hyperfunctioning nodules":1,
"mechanico-destructive":1,
"non-hyperthyroid":1,
"thyrotoxicosis":1,
"immunity":1,
"molecular taxonomy":1,
"non-negative matrix factorization":1,
"Hemorrhage":1,
"Thyroid metastasis":1,
"follicular thyroid adenoma":1,
"preoperative diagnosis":1,
"AFP":1,
"OPN":1,
"Chornobyl accident":1,
"clean-up workers":1,
"radiation doses":1,
"radiation risk analysis":1,
"cyclophosphamide":1,
"lupus nephritis":1,
"systemic lupus erythematosus":1,
"RAF/MEK/ERK":1,
"RAI-refractory DTC":1,
"hollow mesoporous silica nanoparticles":1,
"transferrin":1,
"conventional open thyroidectomy":1,
"endoscopic thyroidectomy":1,
"Cholangiocarcinoma":1,
"Hemangioma":1,
"Hepatic tumor":1,
"Metastatic tumor":1,
"NF-κB signaling":1,
"OTUB2":1,
"miR-29a-3p":1,
"ErbB-2 receptor":1,
"Estrogen receptors":1,
"Hormones":1,
"Lobular carcinoma":1,
"Benign thyroid lesions":1,
"CD10":1,
"Immunohistochemical":1,
"Malignant thyroid neoplasms":1,
"Artificial intelligence":1,
"image classification":1,
"neural network":1,
"CXCL11":1,
"CXCL9":1,
"PPARγ":1,
"primary anaplastic thyroid cancer cells":1,
"vandetanib":2,
"IL-33":1,
"cytokine":1,
"affecting factors":1,
"remnant ablation":1,
"I− deficiency disorders":1,
"I− transport defect":1,
"Na+/I− symporter":1,
"congenital hypothyroidism":1,
"capsular invasion":1,
"indeterminate thyroid lesion":1,
"isthmus nodule":1,
"isthmusectomy":1,
"multifocality":1,
"CUX2":1,
"Bcl-2":1,
"RBM3":1,
"radioresistance":1,
"Akt-mTOR/GSK3β":1,
"Tuft1":1,
"Rheumatoid arthritis":1,
"standardized incidence ratio":1,
"Breast lymphoedema":1,
"Lymphatic obstruction":1,
"Upper extremity lymphoedema":1,
"Endocrine surgery":1,
"BRAF expression":1,
"FNAB":1,
"Immunocytochemistry test":1,
"animal model":1,
"targeted therapy":1,
"proto-oncogene proteins c-ret":1,
"pancreatic metastases":1,
"Aberrant thyroid":1,
"Occult thyroid carcinoma":1,
"Thyroglobulin (Tg) gene expression":1,
"Thyroid carcinoma (TC)":1,
"Thyroid stimulating hormone receptor (TSHR) gene expression":1,
"Bronchogenic carcinoma":1,
"endobronchial metastasis":1,
"flexible bronchoscopy":1,
"Ca2+ flux":1,
"Cell surface":1,
"Kupffer cells":1,
"Lung metastasis":1,
"Nucleolin":1,
"Phagocytosis":1,
"Tumor-derived nanovesicles":1,
"and DOTAP/DOPE liposome":1,
"Familial risk":1,
"Genes":1,
"Urinary tract cancer":1,
"Chernobyl nuclear accident":1,
"Genes, p53":1,
"scalp":1,
"bilateral breast neoplasm":1,
"end results (SEER) database":1,
"nomograms":1,
"laryngeal cancer":1,
"pharyngoesophageal repair":1,
"pharyngoesophageal stenosis":1,
"pharyngoesophageal stricture":1,
"radial forearm free flap":1,
"immediate surgery":1,
"papillary thyroid microcancer":1,
"predictive factor":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2018年第4季度论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAO4AAADICAYAAADvG90JAAAWNElEQVR4Xu2dedS/5ZzHX/6YmVJRKi1ojwqjydaqIilJacgkhFSYM5UkSyiFSpaypIXRiJBjyJqTZBjLjL2hxZpMRqEkSxznzJz3dH1PT0/P83zv5bqv5b7fn3O+5+l3uu/r8/m8r/t9L9f1We6GxQgYgeoQuFt1FttgI2AEMHF9ERiBChEwcSucNJtsBExcXwNGoEIETNwKJ80mGwET19dAbAS2BDYNv/sA9wLWAtYEVpuj7M/Ab8LvZuB64Mrw+3lsQ2sez8Stefby2r4TsBtw/wVEve+AJv0C+BxwOfAZ4GcD6ip+aBO3+CkqxsB1gKcBewK7Aqtntuwa4JPA24CfZLYluXoTNznkVSlcA/h74OnAYwq2/ELgNcBVBdsY1TQTNyqcoxnsAcAxgbB3r8grvUafCVxckc2dTDVxO8E22pM2CRf+Eyv38EvAUcA3KvdjWfNN3LHObHu/TgJe2f60os/Q6/PYfPp/wE3coq+7JMZtD7wf0NN2jPKFsKimraXSZGNgL+BfgNvaGGfitkFrfMe+FDhlfG7dxaNbgBcAWsTKLdrXfirwDGAH4BHA19oaZeK2RWwcx2vB6WOFrxQPgfR5wOFDDDxnTAWePBn4h/CEnR1+EPCBLvYMQdytp7Qs3wX0As5RIMPuBdiRw4QvA/uE6Kyh9e8NHBy21FZZpExrCid0NWAI4upOrjvM/sCtXQ3zeYMhoK2S2leN+4KjMMpdgJv6DrTE+YooU6CKnqYK9VxKPgQc2Ed3bOJuGOJLZdN3wmuBQtUsZSBwLnBYGaZkt+KK8NYRg7wK+3xm+G7daI5nXwce3tf72MQ9GnjzAqO0krcHcHVfQ31+bwQOAD7ce5RxDaCHi67PX3Vwa/0QoKJX4W0bnq/46ocCv2x4/LKHxSbuUt9OyvJ4PPDVvsb6/M4IKPj/v0KGTudBRnqiyKstsSbbMfcMC0xaFW67RqDxHwnoSd9bYhJ3XeDGZSz6Y3BY37+W9AhcBjw6vdpqNCrS6uSQdbSU0SLpc8O3a1en9gU+0fXkxefFJO6hwDvnGPY84JxYxnucRggcApzf6EgfpLfD2RPxr4ENIgWmHAu8MSa8MYnbdLXydcDxMZ3wWMsisCrwY0DfY5Y8CLwbeE5s1TGJ+78tjNNyuFbhmnxXtBjWhy5C4MQ+e4VGszcCegXfufcoSwwQi7jK1fxsSwMV5qX3/htanufDmyGwXkgw11PXkh4BJfdrBVmv39ElFnFPB/Qe31ZUR+hxwHfbnujj5yLwcuC1c4/yAUMg8NuwV/v9IQbXmLGIq62GB3U08vdhtc4rzh0BXOY0VYPYKu6QHq0hAtob1kr+YBKDuMp2+HUEC18GnBphHA9x+yuaInQs6RFQZNq83ZXeVsUgruJeY5UK6R3D2RuRcQxwRqgAMQ5v6vFCuL8whbkxiHsacFxEYxVhtd8KwRwRVY12KMWHa3HKkg6BSwBlAyWRGMRVhQFlWsQUXXgi73/GHHQiYz3Qi33JZ1rZRgpn/F0qzTGIq8WloSoBvgh4UyowRqLn+cBZI/GlBjeUoPAw4Kc9jd0GUHVNBcwofnpF6UtcKRo680erzcpv1A3CMh8BVVRQELwlDQJtSs8oSUG7L1rtF3dmf5UWKGm8xtOXuE8BLkqAj6rWKzF/6JtEAlcGV/E/DnEcHOOZAj1QVGhvsYiIWwSSiqD6t56o2oFZTrQS3ThXui9xXwW8OhFMeuIq5jPFjSKRS9HVbA78MPqoHnApBPQJp/xmkVK/Bweydtk7f0vbXYC+xNXdRgWwUkprJ1Mal1mXFvQ+mtkGq2+HgGIXFMPQSvoSV5Xit2ulMc7B3wrfcT+IM9xoRlHbkKjpY6NBpkxHVKxdRdtbS1/iql7tPVprjXOCkvO16vyOOMONYhStJmtV2VI+AgrUUMBGJ+lDXK2QqQlxblGrRSWLxwi7zO1LX/3qG6s2mJayEdDN9ew+JvYhrlbNSnlVVckcrfANGtjdB+hE5/4I2CyRLqvphoBalr6v26l3nNWHuIoUKa0AnJoc/1NfUCo+v00xg4rdrNZ07a9H2RXpQ9xHAf9WIIR6C1B1jdJuKimgMnFToNxNhyqdfrrbqXc9qw9x1bBI7RxKFRWle/GEuilokVCLhZbyEIien9uHuKrGXnoSgJIVjggNrsqbzrgW3dtlgOICGmE01VRTxtDnI4x1pyH6EPdvmwRDxza443iKcFGbxeXqPncctqjT7gdcV5RF0zZG5WtUlmmQT7Y+xFVol8qj1CICUnnDY63rXNIqfy3XxFB26pNFBei/OZSCPsRVrV4FtNcmAlPB3IOBmgkQ5+FmAn6RWsUTaOFWObqDSR/iyqiaVzHVue4lhQSRxJjgmj5dYvhb4hh6kKldibLZBpW+xFXy8Ly2goM60HNwtVhUGdMxvD4rz1PVNi15EFAnvl1DLevBLehLXIUban+qdtHq+FFDLSQkAidFUYNErlSnRrEDetKqrWwS6Utc9QFqnZKUxLNuSnQjUsaGso9qk01S3e1rA2Zge/UtK9Im3bHoS1xtLF86MDA5hv/XQOBBFxgiO7ZSm9PIqjxcQODbgNrvxOhq3wrUvsRVX5o/tNJY18EXhgofg7WSiAjH6hOKEosIW+ehRNZNAW0zJpe+xJXBCppW7akxi4p4nVLBK3TNq/y1XT9ajMq2MBuDuDsCaic4Bbk8lIuN1lk8MmgmbmRAVxhOZVn1eZJFYhBXhmvfalZiMosjiZWqu+CZgEqhJiuC3cBH2bJag+N8SH8EVLxQnydZJBZxp1qEW9/3Ks72HkDVJ3LLL4F1chsxIf2x+NMasliKVwGunXi/GpFGBP4goKbdOURJBko2sKRBIBZ/WlsbU7Gyb97e2oJxnqCbmMqT6FU6ZdNurX5vOU5Ii/RKrXdUtDC5xCSujFffEy2RW+5AQHvBWpX+SII0yCtCYW7jnwYBFS+4NY2qO2uJTVwVR1+qJUMO30rUqS4DIrD6If37AAb+B6BeNpY0CKyZq+pIbOIKLnVCV0d0y3wEVLNLW2lfDNVE+kbgaDyllFnSILB2jqgpuTYEcUus/phmGvtr0aa+4qT10z6hcju16KW/ioVdKYhdscp6JVfLR0saBNQ8PGmM8sytIYirsY/v2lohDd7WYgSiIKA6X7qxJpehiCtHvgJsn9wjKzQC6RBQ28yb06m7Q9OQxNV+orZCcvUWyoGndU4LAbXhqTbJYKWp2gcoNa53WpeYvR0CAYWXZsmOG/KJOwNKja/VANtiBMaGQAr+LIlZKsVKTH/S2GbN/kwegVT8uQvQXRQfCagrfFvRXuXObU/y8UagUASUibVGLtvaEndWZUElO5Q8r0igpiInFTG0W9MTfJwRKBiBGwDVFs8ibYm7MGle+YhHA+9sablCIhUaaTECNSOgXsTqHpFF2hL3ucB5iyxVaVPl47bpDHAicEIWj63UCMRB4DvAtnGGaj9KW+KeFvrvLKXpvaEuU9PKiAcAFwBKjbIYgdoQUJLILrmMbktckfPgOcZ+FjgbUIe8eaLcUWXLqO+NxQjUhIDWa/bLZXBb4l4SWgc2sVcf76oIIWIq/HE50RP3WOAYQJEoFiNQAwL/DByay9C2xNX3rBpatxU1Q7osEFhlXX4Ssl80jkIj1bBKokZcG7Yd3McbgQwIvD40jcugun1an5pKqbmUxQhMHQH1Wj49Fwhtn7haeNo6l7HWawQKQuA5wLtz2dOWuAq8eEguY63XCBSEwN6A1nyySFviuqZRlmmy0gIR0LpMtn7EbYmrrR51J7MYgakjkC2JXsC3Ja6KfR849Rmz/0agA3eigtaWuCp4rsLnFiMwZQTUgT5rr6y2xFWgRLYl8ClfKfa9KAT0yfjYnBa1Je4TgI/nNNi6jUABCCikV4k12aQtcVW7V1FPFiMwZQT05vnGnAC0Ja5sVQyy6slajMBUEdgfuDin812IK4OfmNNo6zYCmRFQ2O/3ctrQhbhHAWfkNNq6jUBmBFYFbstpQxfiqo2m2mlajMAUEbgG2Cq3412IK5tVtmOWipfbB+s3AikRUGO17EFIXYmrInFvTomWdRmBQhB4ZQkN7boSV5UqflMIkDbDCKREIPuKspztSlyd+y5AOYkWIzAlBDYGrsvtcB/ibgaotqzFCEwFATUbX7cEZ/sQV/afAxxegiO2wQgkQEDhvkXEMPQl7gaAMiXUbtBiBMaOQBELU32/cWeTpDQ/pftZjMDYEdgTuLQEJ/s+cWc+fBnYoQSHbIMRGBCBbB3oF/sUi7haafsuoG5+FiMwRgS+BWxXimOxiCt/9g1tNEvxzXYYgZgIKOBI3TaKkJjElUOvBV5ehGc2wgjEReBJwEfjDtl9tNjElSVn5a4O0B0On2kElkVgbeCmUvAZgrjy7UzgyFKctB1GoCcCRX3fypehiKux9cqsV2eLEagdgZOBV5XkxJDElZ+7AkqDKiJMrCTgbUtVCDwSUKfKYmRo4srR9UPn+T2K8dqGGIHmCBQTn7zQ5BTEnelTE2BVxnPz6uYXjY/Mj4A68hWXBZeSuJoCNa3WqvN++efDFhiBRggoqaC4WuKpiTtDavtQRcANxBpdOz4oEwK3AvfIpHtFtbmIOzNqF+DVwO4lgmObJo/Ae4BDSkQhN3FnmGwR8nqf5RXoEi+TydqkMN5PlOh9KcRdiM1BIe55N0D5vhYjkAOBW4A1cyhuorNE4i60W60MtRcsEu8MbNTEKR9jBCIgcC5wRIRxBhmidOIudlo9i3YMub9a4HoYcPdBkPGgU0dgJ0B55kVKbcRdCKIIrJhokddiBGIioCKIWncpVmojrkInDwAOBrQibTECQyBQTG2p5ZzLQdxtgFeE0q7XAj8F/rKMgSKqgjY2D9+6bnsyxGXqMRcjUETt5JWmJQdxtVJ3s68VI1AoAh8Jb3WFmne7WTmIK71fBZRxYTECpSGgXYwvlGbUYntyEfc44LTSwbF9k0PgKkCfcsVLLuK6x27xl8YkDXw2cH4NnucirrD5YgiqqAEn2zh+BIrMu10O9pzEPQxQdIrFCJSAwLEhX7wEW+bakJO4qwLXA2vNtdIHGIFhEVCv5/sBvxtWTbzRcxJXXiilr6giXPGg9UgVIXAScEJF9mbbDpphtE4IwHC8cU1Xzbhs/UNIXvl1TW7lfuIKK4WX6Y5nMQI5ENAbn8qvViUlEFe9dRXUvV5VyNnYMSBwI7AZ8PvanCmBuMJMxeOK6ctS2yTa3s4IPA84p/PZGU8shbiC4EJA1S8sRiAFAlcDW6dQNISOkoir5IMrXa5miGn2mEsgsBfwmVqRKYm4wnDbUHVAe7wWIzAUAh+rvbZ3acTVRKkA9cVDzZjHNQJh++dnNSNRInGF50uAU2sG1rYXi4A6SKqQQ9VSKnEF6hnAUVWja+NLQ0Dbjg8CbivNsLb2lExc+aKGSyqSbjECMRB4BPC1GAPlHqN04gqfC4Cn5wbK+qtH4A3Ai6v3IjhQA3Fl6vGhSdhYcLcfaREovtxqWzhqIa78UnSVgjSckNB2ln383wHfHhMMNRFXuD8YuAjYakyTYF8GRaCqBPmmSNRG3Jlf6mBwZFMnfdxkEbgM2GOM3tdKXM2FmmLr1Vn9hCxGYDECqiGlWGT9HZ3UTFxNhrqFK59Xr0MWI7AQgSrqI3edstqJO/Nb9YJOB57aFQifNyoEqkyObzMDYyHuzGd17jsR2KcNCD52VAhcCuw5Ko+WcGZsxJ25+ADgaOCZ3j4a+yV8J/9+HjoRqJv8qGWsxJ1Nmkq/Hgqo0oE6/lnGi4Aaye0ccrrH62XwbOzEXTiBegrvG36PGv3MTstBVWrcbSxxyE2mbkrEXYjHPYH9Q8/dHRzQ0eRSKfqYRwOXF21hZOOmStzFMIrIOwHbAzuGFqCrR8baww2DgAovfHyYocsd1cRdem5eP6ZMknIvv96WPQN4b+9RKhzAxL3rpGkrodoiYhVeg11N/kfgrK4n136eiXvnGdwF+DSgIu2WchHQXr36Tk1WTNw7pl6rkiLtKpO9GupwXBFyx9Vh6nBWmri3Y/sC4O3DweyRIyGguPTXRBqr6mGmTlzt7X4QeEjVszgN4xUJp3ROC2Rvs5lzEp4citF52yfnLDTTfThwXrNDp3HUFJ+42qt9HbD7NKa4ai/VRU832Euq9mIA46dEXNWs0uuWFqEs5SPw38DjphJ73HY6xk7c+wDPDokGm7QFx8dnQ+ArIaa8qi7xKdEaK3EVUSPC+nU45dUUR5eCKhRcYVkBgTERVxUglTjwfLfqrPaa1832/GqtT2h4zcRVfWUVjHtseK3yq3DCCyeyquvDTffrkccd7XC1EVcFwPT6qzQuhSda6kfgU8AhY63GONT0lEpcVW/cBrg/oCAJJb6ruoFlPAj8ETgGOHs8LqXzpATibgpsBqiTmoq96e9900FgTRkQUMe8gwD19LF0QCAFcbcIRBRBNw6/jQJZ/V3aYdIqP0VNpdVc2tIDgT7EVdWIDcMKruoaa89UPz0t1wdE1HV72OZTx4XAN8K37PfG5VYeb1Yirkj4ImANQPG8+qtvzxlZ3TUvz5zVqPVlwKk1Gl6qzfOeuNoXVVf4NUt1wHYVjcDnQjDF1UVbWaFx84grl9YJmRkiscUINEHgupDsrpRJywAINCHuTO2zgLeG1+YBTPGQI0BA9Y1PcbL78DPZhriyRqvCenV2DPDwc1OThtuAc8Nq8Y01GV6rrW2JO/NTkS5vAu5Vq+O2OxoCCqA4GVDfHksiBLoSV+ZphfmlwAtdYC3RbJWl5m1hpVhxxpbECPQh7szU9YCTAJUXsYwbAb0SK+1OBeNvGLerZXsXg7gzDxVwoYgYhbJZxoXAb0MVzDcAN43LtTq9iUncGQJKDlDB6qfUCYmtXoDAr4Azwm6CyGspBIEhiDtzTYkD+gY+rBBfbUZzBBT8r6erM3eaY5b0yCGJO3NE8coKnVTRcYVNWspF4DLgXcD7yzXRlgmBFMSdIa14Z3WG1yq04p0tZSDwTeB9oeud92DLmJO5VqQk7kJjjgCODMnyc430AdER+CHwAeAC4PvRR/eAgyOQi7gzx5Q4r1BKrUQ7mGPY6Vb88EWBsEqxs1SMQG7iLoTuwJCv+fiK8SzN9F8EsoqwXyrNONvTHYGSiDvzQnm+qmC/L7APcO/u7k3yTO2zfjg8WZVWZxkhAiUSdzHMOwQC7w1sN8I5iOGSvlkvBy4GPhljQI9RNgI1EHchgmsDe4Un8p6Awi2nKD8APr/g5wD/iV0FtRF38fQ8FNgJ0FNZP6UdjlFmT9QZWU3UMc5yC59qJ+5iV/U9LCLvCDw81GXeoAUeuQ/Vk/Qq4BpA5V709wrg1tyGWX9ZCIyNuEuhuyqwJaAysZuHvwrHVDVKkVrVKlOJYn/VPlI/pcNdG/ZRRdIrUxlhPfUjMAXizpulVUJZWZFYP0V1rQWsFvKM/yb81XGz318Bfwo/pbrN/lt/Z/++ZRFJXfx73kz4/zdGwMRtDJUPNALlIGDiljMXtsQINEbAxG0MlQ80AuUgYOKWMxe2xAg0RsDEbQyVDzQC5SBg4pYzF7bECDRG4P8A3SKu5/rwGYoAAAAASUVORK5CYII=';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
